A light fixture that kills harmful bacteria developed at the University of Strathclyde in Glasgow, Scotland has now been made into a product and introduced in hospitals in the US and Canada.
The fixture called Indigo-clean made by Kenall out of Kenosha, Wisconsin, can be installed into the ceiling like any other light fixture.
When activated, the light fixture emits light at a wavelength of 405 nanometers (nm). The indigo light produces chemical reactions that halts the growth and reproductive abilities of the bacteria.
The indigo light inactivates a wide range of micro-organisms including MRSA (Methicillin-resistant Staphylococcus aureus), C.difficile and VRE (Vancomycin-resistant Enterococcus).
"We have spent more than 13 years researching and developing HINS-light technology for the purpose of reducing the environmental transmission of pathogens and ultimately reducing HAI (Hospital Acquired Infections) in the healthcare setting," said MacGregor, ROLEST founder/co-director and Vice-Principal of Strathclyde.
Cliff Yahnke, Kenall's Director of Clinical Affairs, said, "Breaking the chain of infection, from an infected patient, to the environment, to new patient, is vitally important, and the ability of this technology to be in use and effective at all times, will make a huge difference."
The light is safe for use in the presence of patients and staff. It can be left on continuously to provide all day protection against pathogens on surfaces and floating in the air.
Depending on the facility's needs, the fixture is available in three varieties: blended white, indigo-only or switchable white/indigo.